The detection and characterization of chemical adducts on proteins is of increasing interest. Here, we described a step-by-step procedure to identify unknown chemical adduct modifications on proteins resulting from the interaction with a given reactive compound. The protocol can be divided into two equally important parts: (1) the wet laboratory work, to produce high quality mass spectrometry (MS) data of in vitro modified proteins and (2) the dry laboratory work, to analyze the generated MS data and provide highly confident qualitative and quantitative results on the chemical composition and amino acid localization of adducts. This protocol is applicable to the study of any pharmaceutical or chemical compound forming covalent protein adduc...
Covalent binding of reactive metabolites of drugs to proteins has been a predominant hypothesis for ...
Hemoglobin and serum albumin, two prevalent proteins in human blood, contain unbound cysteine thiol ...
A variety of therapeutic drugs can undergo biotransformation via Phase I and Phase II enzymes to rea...
Protein covalent adducts formed upon exposure to reactive (mainly electrophilic) chemicals may lead ...
Protein covalent adducts formed upon exposure to reactive (mainly electrophilic) chemicals may lead ...
Proteins contain many sites that are subject to modification by electrophiles. Detection and charact...
In this article, an overview of themethods that are currently available for retrospective detection ...
Drugs are often metabolized to reactive intermediates that form protein adducts. Adducts can inhibit...
The reaction products of electrophiles in vivo can be measured as adducts to the abundant proteins, ...
The reaction products of electrophiles in vivo can be measured as adducts to the abundant proteins, ...
The reaction products of electrophiles in vivo can be measured as adducts to the abundant proteins, ...
The reaction products of electrophiles in vivo can be measured as adducts to the abundant proteins, ...
Our current knowledge of the occurrence of proteins covalently modified by reactive carbonyl species...
Protein modifications by reactive intermediates may have a causal role in cellular toxicity but info...
Mass spectrometry has critical roles in analytical chemistry, biomedical research and the diagnosis ...
Covalent binding of reactive metabolites of drugs to proteins has been a predominant hypothesis for ...
Hemoglobin and serum albumin, two prevalent proteins in human blood, contain unbound cysteine thiol ...
A variety of therapeutic drugs can undergo biotransformation via Phase I and Phase II enzymes to rea...
Protein covalent adducts formed upon exposure to reactive (mainly electrophilic) chemicals may lead ...
Protein covalent adducts formed upon exposure to reactive (mainly electrophilic) chemicals may lead ...
Proteins contain many sites that are subject to modification by electrophiles. Detection and charact...
In this article, an overview of themethods that are currently available for retrospective detection ...
Drugs are often metabolized to reactive intermediates that form protein adducts. Adducts can inhibit...
The reaction products of electrophiles in vivo can be measured as adducts to the abundant proteins, ...
The reaction products of electrophiles in vivo can be measured as adducts to the abundant proteins, ...
The reaction products of electrophiles in vivo can be measured as adducts to the abundant proteins, ...
The reaction products of electrophiles in vivo can be measured as adducts to the abundant proteins, ...
Our current knowledge of the occurrence of proteins covalently modified by reactive carbonyl species...
Protein modifications by reactive intermediates may have a causal role in cellular toxicity but info...
Mass spectrometry has critical roles in analytical chemistry, biomedical research and the diagnosis ...
Covalent binding of reactive metabolites of drugs to proteins has been a predominant hypothesis for ...
Hemoglobin and serum albumin, two prevalent proteins in human blood, contain unbound cysteine thiol ...
A variety of therapeutic drugs can undergo biotransformation via Phase I and Phase II enzymes to rea...